October 15th 2024, 9:00pm
By Ashley Chan
Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active surveillance.
October 15th 2024, 7:00pm
By Alex Biese
As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.
October 15th 2024, 5:00pm
By Bonnie Annis
When I underwent surgery for breast cancer, reconstruction was highly recommended, but I decided to remain flat — a decision I think about sometimes.
October 15th 2024, 3:00pm
By Darlene Dobkowski, MA
An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.
October 15th 2024, 1:00pm
A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.
October 14th 2024, 9:00pm
For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone surgery and chemotherapy.
October 14th 2024, 7:00pm
By Spencer Feldman
TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.
October 14th 2024, 5:00pm
By Felicia Mitchell
When natural disasters come, they affect everybody, including people dealing with cancer. I hope for speedy recoveries to patients affected by Hurricane Helene.
October 14th 2024, 4:29pm
By Joseph F. Renzulli MD, FACS
Panelists discuss how the PSA test is conducted and interpreted, and clarify the definitions of high-risk and advanced prostate cancer types, including their implications for prognosis and subsequent treatment decisions.
October 14th 2024, 4:22pm
Panelists discuss how identifying the right candidates for prostate cancer screening and understanding the role of routine screenings versus symptom-driven assessments are essential for early diagnosis and effective management.
October 14th 2024, 3:00pm
An expert explained how radiation may be a treatment option for patients with renal cell carcinoma to manage symptoms and control the disease.
October 14th 2024, 1:00pm
By Harley Durham
During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of AML.
October 13th 2024, 6:00pm
By David Lorber
Two patients reflected on how extraordinary their oncology nurses are — even noting that they forget about their cancer when talking with their nurses.
October 12th 2024, 6:00pm
The drug combined with chemotherapy demonstrated a 60% increase in progression-free survival, suggesting signs of an FDA approval.
October 12th 2024, 3:00pm
By Jacqueline Greer
Scans for cancer are never easy, especially when waiting for the results, but I’ve found ways to help me through these intimidating moments.
CR&T Honors Dr Richard T. Silver with its Humanitarian Award
CPAN News Bulletin – October 2024
Triage Cancer Hosts Final 2024 Conference
The Importance of Precision Medicine: The Next Frontier in Treatment